Table of Content
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Method
1.1.2 Regional Scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.2 Volume price analysis (model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective – 1
1.8.2 Objective – 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Method
2.2.2 Region
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Trends & Outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.3.1 Penetration Analysis
3.3.2 Market Driver analysis
3.3.2.1 Rise in government and NGO initiatives to promote contraceptive methods
3.3.2.2 High unmet needs
3.3.3 Market Restraint Analysis
3.3.3.1 Rapidly aging population and rising prevalence of infertility
3.3.3.2 Adverse effects associated with use of contraceptive drugs and devices
3.4 Hormonal ContraceptiveMarket: Business Environment Analysis Tools
3.4.1 Hormonal Contraceptive Market: PESTle Analysis
3.4.2 Hormonal Contraceptive Market: Porter’s Five Forces Analysis
3.5 Regulatory & Reimbursement Scenario
Chapter 4 Hormonal Contraceptive Market: Method Analysis
4.1 Hormonal Contraceptive Method Market Share Analysis, 2018 & 2026
4.2 Hormonal Contraceptive Method Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the Method Segment
4.3.1 Pills
4.3.1.1 Pills market, 2015 – 2026 (USD Million)
4.3.2 Intrauterine Devices (IUD)
4.3.2.1 IUD market, 2015 – 2026 (USD Million)
4.3.3 Injectale
4.3.3.1 Injectable market, 2015 – 2026 (USD Million)
4.3.4 Vaginal Ring
4.3.4.1 Vaginal ring market, 2015 – 2026 (USD Million)
4.3.5 Implant
4.3.5.1 Implant market, 2015 – 2026 (USD Million)
4.3.6 Patch
4.3.6.1. Patch market, 2015 – 2026 (USD Million)
Chapter 5 Hormonal ContraceptiveMarket: Regional Analysis
5.1 Hormonal Contraceptive Regional Market Share Analysis, 2018 & 2026
5.2 Hormonal Contraceptive Regional Market: Segment Dashboard
5.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
5.4 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
5.4.1 North America
5.4.1.1 North America hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.1.1.1 U.S.
5.4.1.1.1.1 U.S. hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.1.1.2 Canada
5.4.1.1.2.1 Canada hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.2 Europe
5.4.2.1 Europe hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.2.1.1 UK
5.4.2.1.1.1 UK hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.2.1.2 Germany
5.4.2.1.2.1 Germany hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.3 Asia Pacific
5.4.3.1 Asia Pacific hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.3.1.1 Japan
5.4.3.1.1.1 Japan hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.3.1.2 China
5.4.3.1.2.1 China hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.4 Latin America
5.4.4.1 Latin America hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.4.1.1 Brazil
5.4.4.1.1.1 Brazil hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.4.1.2 Mexico
5.4.4.1.2.1 Mexico hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.5 Middle East and Africa (MEA)
5.4.5.1 MEA hormonal contraceptive market, 2015 – 2026 (USD Million)
5.4.5.1.1 South Africa
5.4.5.1.1.1 South Africa hormonal contraceptive market, 2015 – 2026 (USD Million)
Chapter 6 Competitive Analysis
6.1 Strategic Framework/Competition Categorization
6.3 Marketing Channels
6.3.1 Direct marketing
6.3.2 Indirect marketing
6.4 Strategy Mapping
6.5 Hormonal Contraceptive Competitive Landscape: Market Position Analysis (Based on products, Market Presence, and Recent Updates/Strategic Initiatives)
6.6 Company Profiles
6.6.1 Allergan
6.6.1.1 Company overview
6.6.1.2 Financial performace
6.6.1.3 service benchmarking
6.6.1.4 Strategic initiatives
6.6.1.5 SWOT analysis
6.6.2 Bayer AG
6.6.2.1 Company overview
6.6.2.2 Financial performace
6.6.2.3 Service benchmarking
6.6.2.4 Strategic initiatives
6.6.2.5 SWOT analysis
6.6.3 Merck & Co., Inc.
6.6.3.1 Company overview
6.6.3.2 Financial performace
6.6.3.3 Service benchmarking
6.6.3.4 Strategic initiatives
6.6.3.5 SWOT analysis
6.6.4 Pfizer
6.6.4.1 Company overview
6.6.4.2 Financial performace
6.6.4.3 Service benchmarking
6.6.4.4 Strategic initiatives
6.6.4.5 SWOT analysis
6.6.5 Afaxys, Inc.
6.6.5.1 Company overview
6.6.5.2 Financial performace
6.6.5.3 Service benchmarking
6.6.5.4 Strategic initiatives
6.6.5.5 SWOT analysis
6.6.6 Teva Pharmaceutical Industries Ltd
6.6.6.1 Company overview
6.6.6.2 Financial performace
6.6.6.3 Service benchmarking
6.6.6.4 Strategic initiatives
6.6.6.5 SWOT analysis
6.6.7 Agile Therapeutics
6.6.7.1 Company overview
6.6.7.2 Financial performace
6.6.7.3 Service benchmarking
6.6.7.4 Strategic initiatives
6.6.7.5 SWOT analysis
6.6.8 Apothecus Pharmaceutical Corp.
6.6.8.1 Company overview
6.6.8.2 Financial performace
6.6.8.3 Service benchmarking
6.6.8.4 Strategic initiatives
6.6.8.5 SWOT analysis
TABLE 1 List of secondary sources
TABLE 2 List of secondary sources
TABLE 3 North America hormonal contraceptive market, by country, 2015 - 2026 (USD Million)
TABLE 4 North America hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 5 U.S. hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 6 Canada hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 7 Europe hormonal contraceptive market, by country, 2015 - 2026 (USD Million)
TABLE 8 Europe hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 9 UK hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 10 Germany hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 11 Asia Pacific hormonal contraceptive market, by country, 2015 - 2026 (USD Million)
TABLE 12 Asia Pacific hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 13 Japan hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 14 China hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 15 Latin America hormonal contraceptive market, by country, 2015 - 2026 (USD Million)
TABLE 16 Latin America hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 17 Brazil hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 18 Mexico hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 19 Middle East and Africa hormonal contraceptive market, by country, 2015 - 2026 (USD Million)
TABLE 20 Middle East and Africa hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
TABLE 21 South Africa hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
【レポートのキーワード】
ホルモン避妊薬、薬、子宮内器具(IUD)、注射剤、膣リング、インプラント、パッチ
【免責事項】
https://www.marketreport.jp/reports-disclaimer